Table 2 Distribution of the baseline characteristics between the study groups.
| Variables | Medication | p Value* | |
|---|---|---|---|
| BIG (n = 58) | SIG (n = 62) | ||
| Gender (%) | 0.38 | ||
| Male n = 23 (19) | 13 (56.5) | 10 (43.5) | |
| Female n = 97 (81) | 45 (46.4) | 52 (53.6) | |
| Age (years)† | 41.3 (12.9) | 41.7 (10.7) | 0.85 |
| Weight (kg)† | 67.1 (10.8) | 69.8 (11.8) | 0.20 |
| Headache score† | 8.2 (1.7) | 8.1 (1.7) | 0.34 |
| Respiratory rate (beats/min)† | 16.84 (1.9) | 17.05 (1.92) | 0.094 |
| Pulse rate† | 80.95 (11.24) | 82.77 (10.35) | 0.45 |
| SBP (mm Hg)† | 126.8 (21.5) | 129.2 (20.6) | 0.32 |
| DBP (mm Hg)† | 76.2 (12.8) | 81.7 (12.1) | 0.03 |
| Body temperature (°C)† | 36.2 (0.4) | 36.2 (0.5) | 0.91 |
BIG, bolus infusion group; DBP, diastolic blood pressure; SBP, systolic blood pressure; SIG, slow infusion group.
*p values from χ2 and t tests.
†Mean (SD).